肠道微生物组与肝脏疾病
综述指出肠道微生物组是多种肝脏疾病病理生理的重要参与者,酒精性肝病、非酒精性肝病和原发性硬化性胆管炎与微生物组改变相关,肝硬化时下消化道口腔微生物组过度代表,肝性脑病等并发症可被益生元、益生菌和抗生素有效治疗。
要点
- 酒精性肝病、非酒精性肝病和原发性硬化性胆管炎与肠道微生物组改变相关。
- 肝硬化时下消化道口腔微生物组过度代表,可能参与疾病进程与严重程度。
- 肝性脑病等严重肝病并发症可被多种益生元、益生菌和抗生素有效治疗。
核心结论
- 肠道微生物组是多种肠道及肠外疾病病理生理的新重要参与者。
- 更好地理解肝脏疾病中的肠道微生物组及其组分可能提供这些复杂疾病的更完整图景,并形成新疗法的基础。
研究设计与样本
- 综述,总结肠道微生物组与肝脏疾病相关性的现有证据。
主要发现
- 酒精性肝病、非酒精性肝病和原发性硬化性胆管炎与微生物组改变相关。
- 菌群失调可能通过与宿主免疫系统及其他细胞类型的多重相互作用影响肝脏脂肪变、炎症和纤维化程度。
- 肝硬化时下消化道口腔微生物组过度代表,可能参与疾病进程和严重程度。
- 肝性脑病等严重肝病并发症可被多种益生元、益生菌和抗生素有效治疗。
局限性
- 肝脏疾病临床宏基因组研究结果有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The gut microbiota has recently evolved as a new important player in the pathophysiology of many intestinal and extraintestinal diseases. The liver is the organ which is in closest contact with the intestinal tract, and is exposed to a substantial amount of bacterial components and metabolites. Various liver disorders such as alcoholic liver disease, non-alcoholic liver disease and primary sclerosing cholangitis have been associated with an altered microbiome. This dysbiosis may influence the degree of hepatic steatosis, inflammation and fibrosis through multiple interactions with the host's immune system and other cell types. Whereas few results from clinical metagenomic studies in liver disease are available, evidence is accumulating that in liver cirrhosis an oral microbiome is overrepresented in the lower intestinal tract, potentially contributing to disease process and severity. A major role for the gut microbiota in liver disorders is also supported by the accumulating evidence that several complications of severe liver disease such as hepatic encephalopathy are efficiently treated by various prebiotics, probiotics and antibiotics. A better understanding of the gut microbiota and its components in liver diseases might provide a more complete picture of these complex disorders and also form the basis for novel therapies.
引用
- Tilg H, Cani PD, Mayer EA, et al. Gut microbiome and liver diseases. Gut. 2016. PMID: 27802157. doi:10.1136/gutjnl-2016-312729
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。